TG Therapeutics (TGTX) Reports Q4 Loss of $0.48/Share

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), versus ($0.37) reported last year.

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings